Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	11,064	11,155	12,302	9,348	9,415	10,242
Market Cap Growth	-15.35%	-9.32%	31.60%	-0.71%	-8.08%	49.25%
Enterprise Value	10,980	11,097	11,669	8,972	9,322	10,305
Last Close Price	13.28	13.13	14.53	11.21	10.90	11.97
PE Ratio	17.57	16.86	18.41	17.03	30.32	43.47
PS Ratio	2.87	2.93	3.67	3.12	3.33	3.95
PB Ratio	2.75	2.83	3.65	3.32	3.75	4.33
P/TBV Ratio	4.05	4.24	4.28	3.92	4.50	5.64
P/FCF Ratio	-	50.37	35.31	16.14	53.13	28.86
P/OCF Ratio	-	20.53	22.56	13.04	25.42	20.99
EV/Sales Ratio	2.85	2.91	3.48	3.00	3.30	3.97
EV/EBITDA Ratio	11.40	10.67	12.26	11.16	14.82	16.50
EV/EBIT Ratio	14.49	12.98	14.82	13.79	19.70	22.91
EV/FCF Ratio	-	50.10	33.49	15.50	52.61	29.04
Debt / Equity Ratio	0.16	0.14	0.07	0.06	0.18	0.18
Debt / EBITDA Ratio	0.68	0.52	0.25	0.20	0.71	0.66
Debt / FCF Ratio	-	2.47	0.69	0.28	2.52	1.17
Asset Turnover	-	0.74	0.79	0.80	0.77	0.76
Inventory Turnover	-	2.01	2.06	2.14	2.09	2.15
Quick Ratio	-	1.16	1.72	1.58	1.24	1.07
Current Ratio	-	1.92	2.58	2.38	1.93	1.78
Return on Equity (ROE)	-	18.53%	21.77%	21.38%	12.96%	10.51%
Return on Assets (ROA)	-	10.37%	11.56%	10.86%	8.04%	8.27%
Return on Invested Capital (ROIC)	14.95%	19.98%	25.30%	21.99%	15.03%	13.42%
Return on Capital Employed (ROCE)	-	20.10%	22.50%	22.60%	18.10%	18.10%
Earnings Yield	5.69%	5.93%	5.43%	5.87%	3.30%	2.30%
FCF Yield	-	1.98%	2.83%	6.19%	1.88%	3.46%
Dividend Yield	0.52%	0.71%	0.66%	0.87%	0.73%	0.57%
Payout Ratio	9.46%	11.78%	11.94%	11.05%	17.59%	24.06%
Buyback Yield / Dilution	0.07%	-0.08%	-0.19%	-0.03%	-0.01%	-0.14%
Total Shareholder Return	0.59%	0.64%	0.47%	0.84%	0.71%	0.43%

Updated Jan 21, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q